PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

A new achievement in obtaining durable antibacterial protection for vascular prostheses

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Gentamicin covalently bound to bead shaped silica supports or Tricogel (vascular prosthesis) demonstrates stability for even up to 30 days. A comparison was made of the results of gentamicin immobilization to silica supports or Tricogel pieces activated in two modes. Gentamicin retention (during a 30-day experiment) on the Tricogel was shown to be higher than that on silica supports. The release of gentamicin from four matrices was observed only during the first 4 days of the 30-day experiments. The biological activity of gentamicin against "Escherichia coli", "Pseudomonas aeruginosa" and "Staphylococcus aureus" was also checked. In these experiments we used samples of Tricogel irradiated in UV (control), soaked in gentamicin solution or containing gentamicin covalently bound to this matrix. The covalently bound gentamicin was shown to inhibit completely the growth of all the three bacterial strains during the experiment.
Twórcy
autor
  • Departament of Biochemistry, Maria Curie-Skłodowska University, 20-031 Lublin, Poland
autor
  • Departament of Biochemistry, Maria Curie-Skłodowska University, 20-031 Lublin, Poland
  • Departament of General Microbiology, Maria Curie-Skłodowska University, Lublin, Poland
autor
  • Division of General and Vascular Surgery, Municipal Hospital, Rzeszów, Poland
  • Departament of Biochemistry, Maria Curie-Skłodowska University, 20-031 Lublin, Poland
Bibliografia
  • [1] Gottenbos B., van der Mei H.C., Klatter F., Nieuwenhuis P., Busscher H.J.: In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 2002, 23, 1417-1423.
  • [2] Schmitt D.D.: Antibiotic usage in prevention and treatment of graft infection, In: R.B. Rutheford (Eds.), Seminars in Vascular Surgery, W.B. Sanders, Philadelphia 1990, 3, 122-132.
  • [3] Lindenauer S.M., Fry W.J., Schaub G., Wilde D.: The use of antibiotics in the prevention of vascular graft infections. Surgery 1967, 62, 487-492.
  • [4] Kaiser A.B.. Clayson K.R., Muherin J.L. etal: Antibiotic prophylaxis in vascular surgery Ann Sure 1978 , 283-288.
  • [5] Gelabert H.A., Colburn M.D.: Development and results of antibiotic impregnated vascular grafts, In: W.S. Moore and H.A. Gelabert (Eds.), Antibiotic impregnated vascular grafts, Medical Intelligence Unit, Austin 1992, 88-100.
  • [6] Haverich A., Hirt S., Karck M., Siclari F., Wahling H.: Prevention of graft infection by bonding gentamicin to Dacron prostheses. J.Vasc. Surg. 1992, 15, 187-193.
  • [7] Bonzon N„ Lefebvre F„ Ferre N„ Daculsi G„ Rabaud M.: New bioactivation mode for vascular prostheses made of Dacron® polyester. Biomaterials 1995, 16, 747-751.
  • [8] Hirt S.W., Aoki M„ Demertzis S„ Siclari F„ Haverich A., Borst H.G.: Comparative in vivo study on the healing qualities of four different presealed vascular prostheses. J. Vase. Surg. 1993, 17, 538-545.
  • [9] Engbers G.H., Feijen J.: Current techniques to improve blood compatibility of biomaterial surfaces Int. J. Artif. Organs. 1991, 14, 199-215.
  • [10] Sivakumar M., Panduranga Rao K.: Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres. Biomaterials 2002, 23, 3175-3181.
  • [11] Goeau-Brissonniere O., Leflon V., Letort M„ Nicolas M.H.: Resistance of antibiotic-bonded gelatin-coated polymer meshes to Staphylococcus aureus in rabbit subcutaneous pouch model Biomaterials 1999, 20, 229-232.
  • [12] Itokazu M., Yang W., Aoki T., Ohara A., Kato N.: Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing. Biomaterials 1998, 19, 817-819.
  • [13] Puzova H., Siegfrid L„ Kmetova M„ Filka J„ Takacova V., Durovivova J.: Fimbriation, surface hydrophobicity and serum resistance in uropathogenic strain of Escherichia coli. FEMS Immunol Med. Microbiol. 1994, 9, 223-230.
  • [14] British Pharmacopoeia, HMSO, London vol. l 1998, 302.
  • [15] Łobarzewski J., Paszyński A., Wolski T„ Fiedurek J.: Keratin and polyamide-coated inorganic matrices as supports for glucoamylase immobilization. Biochem. Biophys. Res. Commun 1984 121 220-228.
  • [16] Lappi D.A., Stolzenbach F.E., Kaplan N.O., Kamen M.D.: Immobilization of hydrogenase on glass beads. Biochem. Biophys. Res. Commun. 1976, 69, 878-884.
  • [17] Łobarzewski J., Fiedurek J„ Ginalska G„ Wolski T.: New matrices for the purification of pectinases by affinity chromatography. Biochem. Biophys. Res. Commun. 1985, 151, 666-674.
  • [18] Ginalska G„ Uryniak A„ Łobarzewski J., Osińska M.: „Sposób immobilizaeji antybiotyków” Zgłoszenie patentowe Nr P-358934, 2003.
  • [19] Cabanillas P.F., Diez Pena E„ Barrales-Rienda M„ Frutos G.: Validation and in vitro characterization of antibiotic-loaded bone cement release. Int. J. Pharm. 2000, 209, 15-26.
  • [20] European Pharmacopoeia, 3rd Edition Z.J.Z. Microbiological Asay of Antibiotics European Department for the quality of Medicines, Strasbourg 1997.
  • [21] Avramovic J.R., Fletcher J.P.: Rifampicin impregnation of a protein-sealed dacron graft: An infection-resistant prosthetic vascular graft. Aust.N.Z.J.Surg. 1991, 61, 436-440.
  • [22] Mokracka J., Koczura R., Kaznowski A.: Wyspy patogenności. Post. Mikrobiol. 2002, 41, 51-59.
  • [23] Earnshaw J.J.: The current role of rifampicin-impregnated grafts: Pragmatism versus science. Eur. J. Vase. Endovasc. Surg. 2000, 20, 409-412.
  • [24] Gahtan V, Esses G.E., Bandyk D.F., Nelson R.T., Dupont E, Mills J.L.: Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J.Surg.Res. 1995, 58, 105-110.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BPZ1-0011-0002
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.